- Home
- / Prolong Pharmaceuticals
Prolong Pharmaceuticals
Total Funding
$30 M
Prolong Pharmaceuticals Summary
Company Summary
- Overview
- Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. It is engaged in the development of hematology and oncology products.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- South Plainfield, NJ, US | view all locations
- Website
- https://prolongpharma.com/
- Cybersecurity rating
Table of Contents
Key People
Ron Jubin, Vice President, R&D
John Pakulski, Senior Vice President, Regulatory
LocationsView all
1 location detected
South Plainfield, NJ HQ
United States
300 Corporate Ct